Total medical devices industry cross border deals worth $4.5bn were announced globally for October 2022, with the $2.6bn acquisition of The Binding Site Group being the sector’s biggest investment, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 401.8% over the previous month of $892.83m and a rise of 57.8% when compared with the last 12-month average of $2.84bn.
In terms of number of cross border deals, the sector saw a drop of 54.69% with 29 deals in October 2022 when compared to the last 12-month average of 64 deals.
In value terms, Europe led the activity with cross border deals worth $3.87bn in October 2022.
Medical Devices industry cross border deals in October 2022: Top deals
The top five cross border deals accounted for 94.5% of the overall value during October 2022.
The combined value of the top five cross border deals stood at $4.24bn, against the overall value of $4.5bn recorded for the month.
The top five medical devices industry cross border deals of October 2022 tracked by GlobalData were:
1) Thermo Fisher Scientific’s $2.6bn acquisition deal with The Binding Site Group
2) The $1.14bn acquisition of M.A. Med Alliance by Cordis
3) Nordic Capital’s $300m private equity deal for 25% stake with Equashield Medical
4) The $100m venture financing of Xunshi Technology by Chende Capital, SoftBank Vision Fund 2, Yiheng Capital Partners, Yuanyi Capital and Zhongwei Capital HoldingLimited
5) KDB Investment’s $100m private equity deal with Think Surgical